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Alongside the physical symptoms associated with Parkinson’s disease dementia and dementia with Lewy bodies, health services
must also address the cognitive impairments that accompany these conditions. There is growing interest in the use of
nonpharmacological approaches to managing the consequences of cognitive disorder. Cognitive rehabilitation is a goal-orientated
behavioural intervention which aims to enhance functional independence through the use of strategies specific to the individual’s
needs and abilities. Fundamental to this therapy is a person’s capacity to set goals for rehabilitation. To date, no studies have assessed
goal setting in early-stage Parkinson’s disease dementia or dementia with Lewy bodies. Semistructured interviews were carried out
with 29 participants from an ongoing trial of cognitive rehabilitation for people with these conditions. Here, we examined the
goal statements provided by these participants using qualitative content analysis, exploring the types and nature of the goals set.
Participants’ goals reflected their motivations to learn new skills or improve performance in areas such as technology-use, self-
management and orientation, medication management, and social and leisure activities. These results suggest that goal setting is
achievable for these participants, provide insight into the everyday cognitive difficulties that they experience, and highlight possible
domains as targets for intervention. The trial is registered with ISRCTN16584442 (DOI 10.1186/ISRCTN16584442 13/04/2015).
1. Introduction
At least 80% of people diagnosed with Parkinson’s disease
(PD) formore than 20 years develop dementia [1, 2].The clin-
icopathological profile of this PD dementia (PDD) is similar
to that of dementia with Lewy bodies (DLB [3, 4]), a condi-
tion whereby cognitive dysfunction antedates parkinsonism
symptoms. These two syndromes share an almost indistin-
guishable neuropsychological profile, characterised by atten-
tional and executive deficits alongside visuospatial andmem-
ory impairments [5, 6]. Other neuropsychiatric symptoms,
such as hallucinations, depression, anxiety and apathy, may
also emerge in these conditions [7]. Awareness of cogni-
tive problems has received little research attention in both
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disorders. Nonetheless, some studies have indicated that peo-
ple with PD may overestimate their perceived performance
on cognitive tasks and for measures of daily living activities,
when compared with informant ratings [8–11]. The negative
impacts of neuropsychiatric symptoms on the wellbeing of
people with these dementias and their caregivers, as well as
on the broader community, have been noted [12–18]. Health
services are required to support the functional independence
of people with PDD and DLB through monitoring and
managing their cognitive and behavioural changes in the
context of increasing physical deterioration. Pharmacological
treatments for cognitive symptoms are available and include
cholinesterase inhibitors (e.g., rivastigmine) and glutamate
receptor antagonists (e.g., memantine). These drugs, how-
ever, have been associated with adverse side-effects, such as
increased tremor [19]. Furthermore, their use does not always
correspond to improvements in functional independence or
caregiver burden [20].
Nonpharmacological strategies may offer an alternative
approach to the management of neuropsychiatric symptoms
in these conditions. Recent efforts to assess the efficacy and
feasibility of physical and psychological interventions (e.g.,
cognitive training, physical exercise, and participation in
leisure or social activities) on neuropsychological and disease
outcomes in people with PD without dementia have shown
positive, albeit, limited results (for review, see [21, 22]). To
date, no intervention studies have included people with PDD
or DLB and thus the generalisability of these findings to
these patient populations is restricted. In response to this gap,
a pilot trial, entitled “Cognitive Rehabilitation for Parkin-
son’s disease dementia: a pilot randomised controlled trial
(CORD-PD),” assessing the application and potential efficacy
of cognitive rehabilitation (CR) for people with mild to mod-
erate PDD and DLB, is currently underway [23]. This ran-
domised controlled trial (RCT) will compare CR against an
active control condition (relaxation therapy, RT) and treat-
ment as usual (TAU), using participants’ ratings of, and
satisfaction with, performance in relation to goals identified
through an interview conducted by the researcher with the
person with PDD or DLB and, if available, a primary care-
giver. The objective of CR is to promote independence in the
person with early-stage dementia by developing and support-
ing the use of strategies to circumvent the effects of cognitive
difficulties. It uses an individualised approach whereby per-
sonally relevant goals are devised and implemented according
to the individual’s needs and abilities. The intervention is
delivered by a trained therapist who adopts evidence-based
methods and strategies appropriate to the nature of the cog-
nitive goal set. These methods might include compensatory
strategies (such as calendars, diaries, or reminders) and/or
restorative approaches (such as mnemonics and spaced
retrieval) to retain learned information and improvememory
recall. The efficacy of CR, compared with RT and TAU, for
people with early-stage Alzheimer’s disease (AD) has been
demonstrated in a single-centre RCT [24]. A largemulticentre
trial assessing the clinical- and cost-effectiveness of CR as an
intervention for people withAD, vascular, ormixed dementia
is underway.This research is not recruiting people with PDD
or DLB due, in part, to their distinct motor symptoms [25].
The CORD-PD pilot trial will aim to assess the application of
CR in the context of physical disability in these conditions.
Fundamental to the CR procedure is successful goal
setting. This process involves an individual’s capacity to
identify areas of difficulty and devise goals for improvement,
as well as rate and monitor performance and/or satisfaction
with performance in relation to each selected goal. It is not
yet known whether people with PDD and DLB can engage
in effective goal setting for these purposes. Here, we explore
the ability of people with mild to moderate PDD and DLB to
set goals for CR. We will examine what types of goals people
with PDD and DLB set and deem as important, as well as the
nature and themes of their goal statements. A comparison of
goal performance ratings from the perspectives of PDD and
DLB participants and their caregivers will also be conducted.
2. Methods
2.1. Participants. Participantswere recruited fromMovement
Disorder Clinics and Memory Services within the Betsi
Cadwaladr University Health Board (BCUHB), NorthWales,
UK. Caregivers were invited to participate with the PDD
or DLB participant’s permission. Patient participants had
a diagnosis of PD, PDD, or DLB according to consensus
criteria, an Addenbrooke’s Cognitive Evaluation-III (ACE-
III, [26]) score of ≤82, and presented with early- to midstage
dementia according to their clinician. Exclusion criteria
included a diagnosis of any other significant neurological
condition; major psychiatric disorder, including depression,
which is not related to their Parkinson’s disease; and unstable
medication use for their physical or cognitive symptoms.
2.2. Design. Participants were recruited to an ongoing single-
blind pilot trial which aims to assess the feasibility and
efficacy of CR for people with PDD and DLB. This trial,
CORD-PD, compares CR with TAU and an active control
condition, RT. For further information regarding CORD-
PD, please see the study protocol [23]. At the baseline visits,
participants identified up to three rehabilitation goals and
rated their performance and satisfaction with these goals,
using the Bangor Goal Setting Interview (BGSI, [27]). Here,
we explore the nature and types of goals identified by
participants recruited so far to the study, in order to indicate
the extent to which people with PDD and DLB are able to
generate goals as well as what kind of goals they perceive as
personally relevant and meaningful. We compare PDD and
DLB participants’ ratings to their caregivers’ ratings for per-
ceived goal performance from the baseline visits (i.e., prior to
randomisation). Ethical approval for the study was obtained
from the Wales Research Ethics Committee 5 (13/WA/0340).
Consent procedures were conducted in accordance with the
Declaration of Helsinki [28]; informed written consent was
obtained from all participants prior to entry into the trial.
2.3. Measures. Only measures pertinent to the current analy-
ses will be described. For a list and description of measures
used in CORD-PD, please refer to the study protocol [23].
The BGSI [27] was used to identify and rate performance and
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satisfaction with goals set prior to randomisation (see Sec-
tion 2.4). Severity of Parkinsonian symptoms was measured
using the modified Hoehn and Yahr staging criteria [29].
Items from the Unified Parkinson’s Disease Rating Scale-part
three (UPDRS, [30]) were used to assess physical functioning,
with higher scores indicating greater physical impairment (a
maximum score of 92 was created from these item scores).
The Hospital Anxiety and Depression Scale (HADS, [31])
assessed levels of anxiety and depression in the PDD andDLB
participants and their caregivers (where available). Scores
≥ 11 on either subscale qualify for clinical levels of anxiety
and depression symptoms [32]. Demographic information
for participants with PDD or DLB and their caregivers was
recorded at the baseline visits and includes age, sex, number
of years of formal education, and marital status. IBM SPSS
(version 22.0) was used to summarise these data [33].
2.4. Procedures. The BGSI was administered to all partici-
pants at the initial interviews prior to randomisation to the
treatment groups. Specific goals were identified and selected
through collaboration between the researcher, the person
with PDD or DLB, and their caregiver (where available) over
the course of these visits. At this point in time, prior to
randomisation, the participants did not know if they would
be allocated to the CR condition or the control conditions.
The researcher remains blinded to participants’ treatment
allocations throughout their participation in the trial. At
these visits, the researcher discusses the purpose of the CR
intervention and asks participants to consider how they
believe their cognitive difficulties affect their performance of
everyday tasks, their enjoyment of activities and pastimes,
and/or their participation in social activities. From these
discussions, difficulties that the participant deems the most
important and feels the most motivated to overcome are
selected as the basis for possible goals. Aminimumof two and
a maximum of three goals are developed. Goals are further
refined with help from the researcher and caregiver (if avail-
able) to produce a goal statement. Goal statements are spec-
ified according to SMART principles; they are specific, mea-
surable, achievable, realistic, and timed [34]. For this study,
if the participant stated a reason (i.e., a motivation) within
the goal statement for why the goal was selected (e.g., “so my
wife does not have to remind me”), this was included. Once
the goal statement is agreed, the individual with PDD or DLB
rates their current performance and satisfaction with their
performance for these goals on a scale of 1–10, with 1 being
unable to carry out or perform task/extremely dissatisfied
with performance and 10 being able to carry out or perform
task without difficulty/extremely satisfied with performance.
The caregiver, where available, also rates the PDD or DLB
participant’s current goal performance using the same scale.
2.5. Qualitative Analysis. The goals generated by participants
constituted the data set, to which a qualitative content analy-
sis was applied [35]. Following the researcher’s familiarisation
with the data set through reading and rereading the data
items (goals generated by participants), the data were coded
for semantic content which organised the data items into
two overarching categories: a “content” category, covering
Table 1: Mean performance on ACE-III domain scores.
ACE-III domain
(max score)
Patients with PDD and DLB
M SD Min–max 𝑁
Total (100) 71.4 7.6 48–81 29
Attention (18) 14.5 2.4 7–18 29
Memory (26) 14.7 3.4 9–21 29
Fluency (14) 7.7 2.9 0–11 29
Language (26) 22.6 2.1 18–26 29
Visuospatial (16) 11.8 1.2 8–15 29
the types of goals or areas in which goals were set, and a
“motivation” category, covering the motivations expressed by
participantswithin the goal statement as a reason for selecting
the goal.Thedata set was independently reviewed by a second
researcher not associated with the current study but working
on a separate CR trial [36]. The researchers consulted on
the definitions of the final categories and subcategories until
consensus was reached. A subsample of the data set (𝑛 =
23, 30.3%) was coded by the second researcher using the
agreed framework. We used the Multiple Value Nominal
Alpha (version 1.0) software programme [37] to compute
Krippendorff ’s alpha coefficient of reliability [38].The results
of the interrater analysis showed excellent reliability (Krip-
pendorff ’s alpha is 0.95), with percentage agreement being
95.7%.Where interrater discrepancies were found, these were
discussed by the researchers and a consensus was reached.
3. Results
3.1. Participant Characteristics. Twenty-nine participants
with PDD and DLB were recruited (25 PDD, 4 DLB). Median
disease duration (time in years since diagnosis) for these
participants was 4 years (1–21 years). The mean age for
participants was 75.9 (SD = 6.7). The mean UPDRS score for
participants was 30.3 (SD = 9.1). Participants were classified
into the following Hoehn and Yahr stages: Stage 1 (𝑛 = 4,
13.8%); Stage 1.5 (𝑛 = 2, 6.9%); Stage 2 (𝑛 = 6, 20.7%); Stage
2.5 (𝑛 = 3, 10.3%); Stage 3 (𝑛 = 11, 37.9%); Stage 4 (𝑛 = 3,
10.3%). Six (21%) participants were female, in keeping with
reports suggesting higher incidence rates of parkinsonism
and PD in men [39]. The mean number of years of formal
education for participants was 11.1 (SD = 1.7). Participants
had a mean ACE-III score of 71.4 (SD = 7.6). Participants’
mean performance on individual ACE-III domain scores
are shown in Table 1. Participants had mean HADS mood
scores for symptoms of anxiety and depression of 7.6 (SD =
4.1) and 7.0 (SD = 3.7), respectively. Six (20.7%) and three
(10.3%) participants qualified for clinical levels of anxiety and
depression, respectively, according to the criteria.
Twenty-six caregivers were recruited. The mean age for
caregiver participants was 69.6 (SD = 10.6). Twenty-one
(80.8%) of the caregiver participants were female.Themajor-
ity of caregivers were spouses or partners of the person with
PDD or DLB (𝑛 = 22, 84.6%), while the remaining caregivers
were adult children of the person with PDD or DLB. Care-
givers’meanHADSmood scores for symptoms of anxiety and
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Table 2: Mean ratings for PDD and DLB participants’ goal performance and satisfaction.
Goal PDD and DLB performance ratings PDD and DLB satisfaction ratings
Caregiver ratings for PDD and
DLB participants’ performance
M SD Min–max 𝑁 M SD Min–max 𝑁 M SD Min–max 𝑁
1 3.1 1.9 1–6 29 3.3 1.9 1–7 29 2.2 1.3 1–5 24
2 3.2 1.6 1–5 29 3.3 1.7 1–7 29 2.6 1.4 1–5 24
3 2.8 1.5 1–5 18 3.3 2.0 1–8 17 2.3 1.9 1–7 15
Table 3: Categories of goal statements.
“Content” category Definition Count
Technology Learn or relearn how to use a technological device or software 34
Activities or pastimes maintenance Start or maintain an activity or pastime 19
Medication management Develop a medication schedule or remember to take medication on time or at correct dosage 10
Self-management and orientation Orientate self in time or place; plan his/her schedule; record information/events of the day;organise daily functional activities or environment 10
Important items Remember where he/she placed important items or remember to take important items withhim/her to events 2
Social interaction and
communication
Remember names of people and be able to maintain a conversation (e.g., address word
finding and concentration difficulties) 6
Anxiety management Learn strategies to manage anxiety or panic attacks 2
“Motivation” category Definition Count
Relationships Motivated to maintain family and social relationships 7
Knowledge pursuit Motivated to acquire knowledge about current affairs or research personal topics of interest 6
Family benefit Motivated to reduce burden for family or because it is important to family 7
depressionwere 4.8 (SD=2.8) and 3.8 (SD=2.4), respectively.
Only one caregiver showed clinical levels of anxiety according
to the criteria.
3.2. Perceived Goal Performance and Satisfaction with Goal
Performance. Table 2 shows PDD and DLB participants’
and caregivers’ mean ratings for goal performance on the
separate goals. Two caregivers refused to rate their partner’s
performance on goal 1 and goal 2, respectively, because
they were not aware until the interview that their partner
experienced difficulties with these tasks (these goals related
to reading and word-finding difficulties). Table 2 also shows
PDD andDLB participants’mean ratings for satisfactionwith
performance. Mean ratings were in the low range of the 1–10
performance scale which are appropriate for baseline ratings
before the introduction of an intervention and indicative
of good interviewing practice by the researcher. A paired
sample 𝑡-test revealed that PDD and DLB participants’ mean
ratings for perceived goal performance (M = 3.1, SD = 1.6)
were significantly higher than the caregivers’ mean ratings for
PDD and DLB participants’ performance (M = 2.4, SD = 1.5)
[𝑡(65) = 4.6, 𝑝 < 0.001, 𝑑 = 0.5].
3.3. Qualitative Analysis. The 29 PDD and DLB participants
identified 76 goals in total, with 18 participants generating
three goals each and 11 participants generating two goals
each. Table 3 shows the final categories and subcategories
identified from the data set and the frequency with which
these subcategories were endorsed by participants. The next
sections delineate these categories and subcategories with
examples of participants’ goal statements.
3.3.1. Content Category
(1) Technology. Most of the goal statements surrounded
themes of technology-use, such as learning or relearning how
to use personal computers, tablets, or mobile phones:
“I will be able to use email.”
“Use the word processor on my computer to write short
documents.”
“I will be able to use a mobile phone to send and receive
text messages.”
(2) Leisure Pursuit and Maintenance. Another common
theme was maintaining existing or starting new activities or
pastimes:
“I will be able to read for half an hour in a day and
remember what I read.”
“I will be able to prepare a simple pasta dish.”
“I will create a portfolio of twenty-five photos.”
(3) Medication Management. Several participants spoke of
difficulties with managing their medication on their own and
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were motivated to devise or refine their existing medication
schedules in accordance with prescribed times and dosages:
“Devise a medication schedule to remember to take my
medication on time.”
“Refine medication system so that I will be able to take
medication on time at the right dosage when at home
and during the day.”
(4) Self-Management and Orientation. Some participants
indicated an eagerness to manage their own time and daily
activities or to orientate themselves in time or place:
“Within two months, I would like to devise a person-
alised system to keep track of diary appointments and
activities of the care home.”
“I will learn to navigate different rooms of my house
without getting lost.”
“Know the date and keep track of time (morning, mid-
day, evening) during the day.”
(5) Important Items. Some participants expressed frustration
at misplacing everyday items and wanted to use strategies to
retrieve these:
“I will remember where I placed my personal items,
such as my wallet and glasses.”
(6) Social Interaction and Communication. A few partici-
pants expressed social embarrassment at forgetting people’s
names and losing their train of thought or “words” when
in conversation with people. Three participants noted their
word retrieval issues andwanted to understand andovercome
these:
“Identify the reason formyword-finding difficulties and
learn strategies to circumvent these failures.”
“I will remember approximately half of the names ofmy
team-members in my bowls club.”
“I will learn strategies to assist with retrieving the
correct word in conversations with people.”
(7) Anxiety Management. Two participants were strongly
concerned about the anxiety attacks they were experiencing
and wanted to learn strategies to help them cope with these
episodes. One participant experienced separation anxiety
when away from her husband and wanted to remind herself
to use distraction tactics during these separations:
“I will be able to develop and use strategies to overcome
or cope with my anxiety attacks.”
3.3.2. Motivation Category
(1) Relationships. Participants often expressed a desire to use
technology to maintain family and social relationships:
“I would like to learn how to use my mobile phone so
that I can call family members for either social reasons
or emergencies.”
“I will use Skype on the computer to be able call a friend
or family member.”
One participant indicated he was motivated to dedicate
more time to his reading in order to benefit his social
interactions, since his wife complained that he no longer
contributes to conversations:
“I will dedicate one hour per day to read about my topic
of interest (space travel) so that I can have conversations
with people about it.”
(2) Knowledge Pursuit. Several participants wished to acquire
skills in novel technology in order to pursue knowledge or
special interests:
“I will be able to use the laptop to access the internet to
read news articles.”
“I will learn how to use the internet to research bowling
techniques.”
“I want to be able to find information (general knowl-
edge, current affairs) online usingmy desktop and iPad,
within two months.”
(3) Family Benefit. Some goal statements indicated a desire to
benefit family members or relieve them of care duties:
“I will remember to record the events of the day (such
as visits or appointments) to keep track of daily events
so that my daughter is informed.”
“I will select and retrieve items of clothing to wear for
the next day rather than rely on my wife.”
“I will refine my medication system so that I can take
my pills on time without being prompted by my wife.”
4. Discussion
Thefindings presented here indicate that goal setting forCR is
achievable for people with PDD andDLB.They also highlight
participants’ motivation to acquire skills in technology, start
or maintain pastimes, and manage their own time and daily
activities despite their cognitive difficulties. Difficulty in com-
plying with medication regimes was another main category
that emerged from the analysis and poses particular clinical
implications for these patient groups.On average, peoplewith
PDD and DLB rated their current performance for person-
alised goals in the low range, indicating their awareness of dif-
ficulties with these tasks. Nonetheless, relative to informant
ratings, people with PDD or DLB rated their performance as
significantly better for most of the goals prior to the start of
the intervention phase.
To our knowledge, this is the first study to assess goal
setting for CR in PDD and DLB. Earlier research has exam-
ined goal setting in 26 people with PDwithout dementia [40].
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This study classified participants’ goals under domains of
executive function in preparation for an intervention which
comprised strategic executive training. The study reported
that the top three domains in which PD participants set goals
were for “regulation” (goals relating to monitoring and the
execution of tasks), “planning” (goals relating to processes
preceding the execution of a task), and “initiative” (goals that
apply to motivating oneself to start activities or encourage a
positive change in activity level). Moreover, relative to partic-
ipants with acquired brain injury, PD participants set signifi-
cantlymore goals associated with “timemanagement,” which
they defined as goals relating to deficits in estimating time.
Our findings somewhat align with the results of this work.
In particular, participants in our sample showed an eagerness
to orientate themselves in time as well as plan and organise
their leisure and clinical appointments themselves, through
the use of diaries and calendars. Designing or improving their
medication scheduling, as well as increasing their indepen-
dence with this task, would require them to adopt strategies
(e.g., devising a checklist and using an alarm system) to
assist with planning and self-monitoring. The selection of
such goals by our participants may underlie impairments in
these processes leading to cognitive difficulties, particularly
for the prospective aspects of memory. Suboptimal medica-
tion adherence in people with PD has been highlighted by
systematic research [41] which suggested that several factors,
such asmood disorder, cognition, and scheduling complexity
(e.g., polypharmacy), contributed to lack of compliance. Our
participants identified their cognitive difficulties as the main
source of their nonadherence. This finding has important
implications for practitioners assisting people with PD expe-
riencing cognitive difficulties and suggests that they may
require more routine monitoring by clinical staff.
Many participants indicated a desire to maintain or
improve their leisure activity levels, possibly in response to
a self-acknowledged apathy in relation to their usual interests
or a deterioration in their abilities. The desire to learn new
skills, particularly in the area of novel technologies, was most
commonly reported. These skills were often selected for the
purpose of wanting to research current affairs and knowledge
or remain in contact with family members through social
media. A challenge in selecting these goals during the
interview phase was that some activities required a physical
output (such as bowls, cooking, or typing while using a
computer) and both cognitive and physical impairments
contributed to reduced functioning in these areas. It was thus
important to manage participants’ expectations regarding
possible outcomes of the proposed therapy and emphasise
support for their cognitive difficulties with these tasks. People
with early PDD and DLB showed an awareness of the impact
of their cognitive difficulties on their social outcomes and
relationships, with some participants electing to focus on
strategies to help them remember peoples’ names or circum-
vent word retrieval difficulties when in conversation. Further,
some participants showed a desire to improve performance
on certain tasks in order to diffuse burden or responsibility
of care for their relatives.
Interestingly, participants with PDD and DLB rated their
goal performance in the low range, but as significantly better
relative to informant-reports, suggesting that while they show
awareness of the presence of their cognitive difficulties they
might underestimate the severity of these impairments or
their impact on daily life. Impaired awareness in people with
PD for cognitive performance has been suggested previously
[8, 10, 11], but this remains a neglected area of research within
the condition. It is possible that these findings might be
explained by caregivers’ underestimation of their partners’
abilities due to psychological responses or biases. As a group,
the caregivers in our sample did not show clinical levels of
anxiety or depression, but other factors, such as their part-
ner’s cognition, neuropsychiatric symptoms and/or disease
severity, perceived burden, time commitment or relationship
quality with the person with PDD or DLB, might have
influenced their appraisals. Such factors have been suggested
to influence informant-reports of performance for people
with AD [42–46].
This study is not without its limitations. Our sample
size is small which might compromise the representativeness
of our participant groups and the generalisability of these
findings to the wider PDD, DLB, and respective caregiver
populations. Similarly, the PDD and DLB participants were
not severely cognitively or physically disabled which might
have influenced the nature or types of goals selected. Given
the restricted sample size, it is difficult to determine whether
specific impairments in cognitive functions (e.g., attention or
memory as measured by the ACE-III) influenced goal setting
or selection. Moreover, other factors such as predominant
physical symptoms (e.g., tremor, postural imbalance, and
bradykinesia), levels of apathy, and/or personality variables,
which were not assessed here, might have also influenced
this process. Understanding the impact of such factors on
goal setting in these patient groups, and others, should be
explored in larger future studies. The goal setting inter-
view constituted a semistructured approach with discussions
directed around participants’ everyday functioning, social
interaction and leisure activities; this might have excluded
other areas important to participants. Someparticipants prof-
fered their motivations for selecting particular goals within
the goal statement, while others did not. Therefore, some
motivations behind participants’ goal settingmight have been
omitted or implied but not coded within the current analysis.
Participation of the caregiver in the goal setting session,
while benefitting these discussions, may have also influenced
participants’ expressed priorities for rehabilitation.
5. Conclusions
Despite several limitations, this study demonstrates that
people with early-stage PDD and DLB can generate suitable
goals for rehabilitation. It describes the everyday cognitive
difficulties that these individuals experience and highlights
areas of difficulty for targeted intervention. The next steps in
the ongoing trial will be to explore whether implementation
of the CR intervention is feasible for these patient groups
and whether it shows efficacy in producing improvements for
ratings of performance and satisfaction with cognitive goals.
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